19 related articles for article (PubMed ID: 21968131)
1. No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trial.
Dubé MP; Shen C; Greenwald M; Mather KJ
Clin Infect Dis; 2008 Aug; 47(4):567-74. PubMed ID: 18636958
[TBL] [Abstract][Full Text] [Related]
2. Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose-insulin homeostasis in animal models.
Mastan SK; Kumar KE
J Exp Pharmacol; 2010; 2():1-11. PubMed ID: 27186085
[TBL] [Abstract][Full Text] [Related]
3. Lopinavir inhibits insulin signaling by promoting protein tyrosine phosphatase 1B expression.
Kitazawa T; Yoshino Y; Suzuki S; Koga I; Ota Y
Exp Ther Med; 2014 Sep; 8(3):851-855. PubMed ID: 25120613
[TBL] [Abstract][Full Text] [Related]
4. Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically.
Noor MA; Flint OP; Maa JF; Parker RA
AIDS; 2006 Sep; 20(14):1813-21. PubMed ID: 16954722
[TBL] [Abstract][Full Text] [Related]
5. Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes.
Capel E; Auclair M; Caron-Debarle M; Capeau J
Antivir Ther; 2012; 17(3):549-56. PubMed ID: 22293506
[TBL] [Abstract][Full Text] [Related]
6. Short-term AMP-regulated protein kinase activation enhances insulin-sensitive fatty acid uptake and increases the effects of insulin on fatty acid oxidation in L6 muscle cells.
Kelly KR; Abbott MJ; Turcotte LP
Exp Biol Med (Maywood); 2010 Apr; 235(4):514-21. PubMed ID: 20407084
[TBL] [Abstract][Full Text] [Related]
7. Oleate dose-dependently regulates palmitate metabolism and insulin signaling in C2C12 myotubes.
Capel F; Cheraiti N; Acquaviva C; Hénique C; Bertrand-Michel J; Vianey-Saban C; Prip-Buus C; Morio B
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):2000-2010. PubMed ID: 27725263
[TBL] [Abstract][Full Text] [Related]
8. HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.
Richmond SR; Carper MJ; Lei X; Zhang S; Yarasheski KE; Ramanadham S
Biochim Biophys Acta; 2010 May; 1801(5):559-66. PubMed ID: 20117238
[TBL] [Abstract][Full Text] [Related]
9. HIV protease inhibitors induce metabolic dysfunction in part via increased JNK1/2 pro-inflammatory signaling in L6 cells.
Bogachus LD; Turcotte LP
Antiviral Res; 2011 Dec; 92(3):415-23. PubMed ID: 21968131
[TBL] [Abstract][Full Text] [Related]
10. cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.
Sabio G; Davis RJ
Trends Biochem Sci; 2010 Sep; 35(9):490-6. PubMed ID: 20452774
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]